Scientists sit poised at a singular moment in the history of vaccine research. Genomics and systems biology have fuelled advances in our understanding of human immunology. Together with adjuvant development and structure-based design of immunogens, these next-generation technologies are transforming […]
ADITEC’s Scientific and Socio-Economic Impact Report Thomson Reuters Impact Report Published The ADITEC Scientific and Socio-Economic Impact Report by Thomson Reuters, first presented at the European Parliament (click here for the Press Release) and during the H2020 Health Program Committee […]
The European Parliament holds an event on “Vaccine Research and Development in Europe” highlighting the ADITEC success story The Science and Technology Options Assessment (STOA) of the European Parliament, organizes an event “Working Breakfast on Vaccine Research and Development in […]
A shot in the arm for vaccine research Published by the European Commission and features on their website The European Commission highlights the ADITEC project as a success story of EC funded projects. The article, published on the European Commission website, […]
Call for EC Funded Commissioned Research for SMEs and Public Health Organizations Support for Vaccine Development Deadline: Friday 6 May 2016 5:00 p.m. CET Commissioned research for European Small and Medium size Enterprises (SME) and Public Health Organizations The ADITEC […]
Support for Vaccine Development Deadline: Friday 6 May 2016 5:00 p.m. CET The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th Framework Programme of the European Union, aims to accelerate the development of novel and powerful […]
Support for Vaccine Development Deadline: 30 October 2015 5:00 p.m. CET Anticipated Decision Date 30 November 2015 The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th Framework Programme of the European Union, aims to accelerate the […]
Adjuvanted trivalent influenza vaccine study in infants: A randomised controlled trial to determine the kinetics of the functional genomic response In the 2012 influenza season, ADITEC partners (Geneva, Oxford, Emory and Novartis) conducted a randomised controlled trial to assess the kinetics […]
Happy New Year! The ADITEC project team wishes all partners, collaborators and those who are interested in our work, a very Happy New year! In 2015 we will continue developing advanced immunization technologies in order to improve health and wellness. […]
Support for Vaccine Development Deadline: 30 Jan 2015 5:00 p.m. CET Anticipated Decision Date 8 April 2015 The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th Framework Programme of the European Union, aims to accelerate the […]